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Objectives: The delayed Gadolinium-Enhanced MRI of Cartilage (dGEMRIC) technique is a method
proposed for non-invasive measurement of cartilage glycosaminoglycan (GAG) content. In this method,
gadopentetate (Gd-DTPA2) is assumed to distribute in cartilage in inverse relation to the GAG distri-
bution, thus allowing quantiﬁcation of the GAG content. For accurate GAG quantiﬁcation, the kinetics of
Gd-DTPA2 in articular cartilage is of critical importance. However, the diffusion of Gd-DTPA2 has not
been systematically studied over long time periods using MRI-feasible gadopentetate concentrations.
Thus, the present study aims to investigate the diffusion of gadopentetate into cartilage in vitro in intact
and enzymatically degraded cartilage.
Methods: The diffusion of gadopentetate into bovine articular cartilage was investigated at 9.4 T over 18-h
time period using repeated T1 measurements in two models, (1) comparing intact and trypsin-treated
tissue and (2) assessing the effect of penetration direction. The diffusion process was further assessed
by determining the gadopentetate ﬂux and diffusivity. The results were compared with histological and
biochemical reference methods.
Results and conclusions: The results revealed that passive diffusion of Gd-DTPA2 was signiﬁcantly slower
than previously assumed, leading to overestimation of the GAG content at equilibrating times of few
hours. Moreover, Gd-DTPA2 distribution was found to depend not only on GAG content, but also on
collagen content and diffusion direction. Interestingly, the dGEMRIC technique was found to be most
sensitive to cartilage degradation in the early stages of diffusion process, suggesting that full equilibrium
between gadopentetate and cartilage may not be required in order to detect cartilage degeneration.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
In osteoarthritis, the structure and composition of articular carti-
lage are altered and particularly the proteoglycan (PG) content
decreases1. PGs are large protein aggregates consisting of negatively
charged glycosaminoglycan (GAG) side chains which confer a ﬁxed
charge density (FCD) into cartilage2. In order to successfully develop
therapeutic measures, the ability to noninvasively monitor the
structure and composition of cartilage tissue is of utmost importance.
With recently developed quantitative magnetic resonance imaging
techniques it ispossible toprobe the compositionof articularcartilage
and thus enhance the detection of early osteoarthritic changes3e6.: E.-N. Salo, Department of
Box 50, FI-90029 OYS, Oulu,
.
s Research Society International. PThe delayed Gadolinium-EnhancedMRI of Cartilage (dGEMRIC)e
technique is based on the use of a negatively charged, paramagnetic
contrast agent (gadopentetate,Gd-DTPA2) in the imagingof articular
cartilage3. In the technique, the gadopentetate is assumed to
distribute into cartilage in inverse proportion to the FCD induced by
the negatively charged GAG side chains. The spatial concentration of
gadopentetate can be obtained through the measurement of the T1
relaxation times in presence and absence of the contrast agent.
Subsequently, at full equilibrium of the gadopentetate and cartilage,
the FCD can be calculated from the gadopentetate concentration
using the GibbseDonnan principle of electrochemical equilibrium3.
The dGEMRIC technique has already been well established both
in vitro4,7,8 and in vivo9,10. Typically, equilibration times (delays
between contrast agent administration and imaging) of 1.5e3 h11,12
have been used in vivo. However, in recent contrast-enhanced
computed tomography (CECT) studies, it has been shown that full
equilibration of the contrast agentmay take signiﬁcantly longer thanublished by Elsevier Ltd. All rights reserved.
Fig. 1. Schematic drawing of the measurement geometry. The cartilage samples were
ﬁtted inside silicone tubes, and the tubes were placed inside an acrylic sample holder.
The measurement geometry allowed the contrast agent to penetrate only through
superﬁcial or deep cartilage while keeping the other side of the sample moist with PBS.
The acrylic sample holder was further placed inside a larger test tube ﬁlled with PBS to
ensure adequate loading of the coil.
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thediffusion time asamajor sourceof error in theGAGquantiﬁcation,
as an incomplete penetration of the contrast agent will result in
overestimation of the total GAG content.Moreover, the long diffusion
time could explain the uncertainties in the assessment of the GAG
content in deep cartilage using dGEMRIC technique7.
While the results from CECT experiments13,14 suggest that the
full equilibration of contrast agent may not be achieved in a clini-
cally feasible timeframe, the diffusion of gadopentetate into
cartilage has not been systematically studied at MRI-feasible
concentrations over long periods of time. Therefore, the aim of
the present study was to investigate the diffusion of gadopentetate
into bovine articular cartilage in vitro with equilibration times of
18 h. The diffusion was investigated in two models: (1) intact and
enzymatically degraded cartilage and (2) intact cartilage with
varying diffusion routes, i.e. by allowing the penetration of the
contrast agent only through superﬁcial or deep cartilage. Further-
more, the diffusion process was analyzed by determining the
gadopentetate ﬂux and the diffusivity using a ﬁnite element model.
For reference, histological [digital densitometry (DD) of Safranin-O
stained GAGs, polarized light microscopy (PLM)], spectroscopic
[Fourier transform infrared imaging (FTIRI)] and biochemical
[water (H2O), uronic acid (UA) and hydroxyproline (HYP) contents]
measurements were conducted.
Methods
Sample preparation
Intact bovine knee joints (n¼ 12, age 18e22months) were
obtained froma local abattoir (AtriaOyj, Kuopio, Finland). All samples
were prepared from the lateroproximal facet of the patella to mini-
mize variation due to anatomical localization. For the ﬁrst part of the
study, three adjacent full-thickness cartilage disks (d¼ 4 mm, mean
cartilage thickness 1.5 0.4 mm) were prepared from six patellae.
Two of the samples underwent MR imaging and one was used as
a histological control. The tissue adjacent to the imaged samples was
used for biochemical analyses. For the second part of the study,
osteochondral cylinders (d¼ 25 mm) were drilled from six patellae
and cut in two halves. One of the halves was immersed in 1 mg/ml
trypsin to induce GAG depletion (SigmaeAldrich, St. Louis, MO,
USA) (degraded) and the other in phosphate buffered saline
(PBS) containing inhibitors of proteolytic enzymes [5 mM ethyl-
enediaminetetraacetic acid (EDTA) (VWR International LLC, West
Chester, PA, USA) and 5 mM Benzamidine HCl (SigmaeAldrich)]
(control). Both halves were incubated for 2.5 h at 37C. Subsequently,
two adjacent full-thickness cartilage disks (d¼ 4 mm,mean cartilage
thickness 2.10.5 mm) were prepared from both halves. One of the
samples was MR imaged while the other was used as a histological
control. The remaining tissue from both halves was again used for
biochemical analyses. After preparation, all samples were stored
at 20C in PBS containing enzyme inhibitors.
MRI
Prior to imaging, a pair of adjacent cartilage samples was thawed
and the samples were placed inside tight-ﬁtting silicone tubes
allowing gadopentetate penetration only from one direction. The
silicone tubes were further placed into a custom-made, acrylic
sample holder (Fig. 1), which was ﬁlled with PBS. For the ﬁrst part of
the study, a sample was placed in the silicone tube articular surface
up and the adjacent samplewith deep cartilage upwards to allow the
contrast agent penetration only through superﬁcial or deep cartilage,
respectively. For the second part, both treated and non-treated
samples were placed into the tubes articular surfaces up.A 9.4 T vertical magnet (Oxford Instruments Plc, Witney, UK)
with Varian VnmrJ 2.3A console (Varian Inc., Palo Alto, CA, USA) and
a 19 mm quadrature RF tranceiver (RAPID Biomedical GmbH,
Rimpar, Germany) at þ20C was used. Pre-contrast T1 map was
measured in PBS using a saturation recovery fast spin echo (FSE)
sequence (echo train length¼ 4, effective echo time¼ 10 ms,
repetition time¼ 44, 60, 80, 160, 320, 640, 1280, 2560 and 5120 ms,
1 mm slice thickness, 78 mm resolution over cartilage depth,
imaging time per T1 map 6 min 4 s). After the pre-contrast T1
measurement in PBS, the immersion solution above the samples
(the allowed penetration side, Fig. 1) was replaced with 1 mM
solution of Gd-DTPA2 (Magnevist, Bayer Schering Pharma, Berlin,
Germany) in PBS. Post-contrast T1 measurement was started as
soon as possible after the immersion (average delay 2.71.5 min),
using the FSE sequence described above. T1 mapping was repeated
continuously over 18 h, yielding a total of 177 post-contrast T1
maps. After imaging, the samples were immersed in PBS for at least
15 min and processed for histological measurements.
T1 maps were calculated by ﬁtting the data into a mono-
exponential relaxation time equation using MATLAB (Mathworks
Inc., Natick, MA, USA). Depth-wise relaxation time proﬁles were
averaged over 1.5 mmwide region of interest (ROI) at the centre of
each sample. T1 proﬁles were then converted to gadopentetate
concentration (C) proﬁles according to equation C¼ 1/R(1/T1,Gd 1/
T1,PBS)3, where relaxivity R was assumed to be 3.7 mM1 s1 7. For
comparisonwith the reference methods, the concentration proﬁles
were further normalized to 10 points across the cartilage depth
using nearest-neighbour interpolation. In addition to spatial and
bulk values, the contrast agent concentration was analyzed in
superﬁcial (0e20% of relative depth), middle (40e60%) and deep
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were calculated according to the equations reported earlier3.
PLM
Unstained, formalin-ﬁxed parafﬁn-embedded samples were cut
into 5-mm-thick sections. From each sample, three sections were
imaged and averaged. PLM measurements were conducted using
a Leitz Ortholux BK-2 polarized light microscope (Leitz Messtechnik
GmbH, Wetzlar, Germany) equipped with motor-controlled crossed
polarizers, a 2.4 objective, a monochromatic light source (wave-
length l¼ 594 3 nm) and a peltier-cooled 12-bit CCD camera
(Photometrics SenSys, Roper Scientiﬁc Inc., Tucson, AZ, USA). To
determine the orientation angle of the collagen ﬁbrils, each section
was imaged at multiple orientations of the crossed polarizers using
the protocol described by Rieppo et al15. The information on the ﬁbril
orientation angle was used to verify that the enzymatic degradation
had no effect on the properties of the collagen network.
DD
The GAG distribution of the samples was assessed with the DD
of Safranin-O stained histological sections16. The technique is basedFig. 2. Representative gadopentetate concentration maps at 1.5 and 18 h from immersion, Sa
derived collagen distribution map for intact and enzymatically degraded samples. The enzym
and distribution remained unchanged.on the use of a cationic dye which binds stoichiometrically to the
GAG molecules. Optical density (OD), which is linearly related to
the staining and thus to GAG content, was determined by
measuring the absorbance of monochromatic light (wavelength
l¼ 492 5 nm). From each sample, three 3-mm-thick sections were
imaged, analyzed and averaged to obtain the ﬁnal OD proﬁle.
FTIRI
To determine the collagen distribution of the samples, unstained
5-mm-thick microscopic samples were measured using a Perkin
Elmer Spectrum Spotlight 300 imaging system (Perkin Elmer,
Waltham, MA, USA). Spectral range from 2000 to 720 cm1 was
collected with 4 cm1 spectral resolution and a 25 mm pixel size.
The spectra were baseline-corrected and the spatial distribution of
the collagen was estimated by integrating the absorbance of the
Amide I peak (1584e1720 cm1)17.
Biochemical analyses
H2O content, UA content and HYP content of the samples were
determined biochemically. After measuring the wet weights, the
samples were lyophilized, and subsequently the dry weights werefranin-O stained histological section, PLM-derived collagen orientation map and FTIRI-
atically degraded sample showed signiﬁcant GAG depletion, whereas collagen content
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concentration of papain (Sigma) in 150 mM sodium acetate
including 50 mM Cys-HCl (Sigma) and 5 mM EDTA (Merck,
Darmstadt, Germany), pH 6.5, for 3 h at 60C. The samples were
boiled for 10 min to inactivate the enzyme. The UA contents of the
digests were quantiﬁed from the ethanol-precipitated samples18.
To estimate the collagen content of the samples, spectrophoto-
metric assay for HYP was performed after hydrolysis of the freeze-
dried and papain-digested tissue19. The amounts of UA and HYP
were normalized to the wet weights of the samples to compensate
for the variation in the sample sizes.Calculation of the diffusivity and diffusion ﬂux
To determine the diffusivity (D, the constant relating molar ﬂux
and concentration gradient) of gadopentetate in cartilage, a one-
dimensional ﬁnite element model (COMSOL 3.5, COMSOL, Inc.,
Burlington, MA, USA) was created to simulate the distribution ofA
B
C
Fig. 3. Average (n¼ 6 per sample group) contrast agent concentration over time in superﬁc
routes (AeC) and for intact and degraded samples (DeF). Shaded background indicates s
through cartilage surface results in faster equilibration especially in superﬁcial cartilage, w
pentetate accumulation can be seen in degraded layers [Fig. 3(D)].contrast agent20. The model was ﬁtted to the contrast agent
concentration averaged over the full tissue depth at each time point
and the mean square error between the experimental and simu-
lated values was minimized using the unconstrained nonlinear
minimization routine of MATLAB. The diffusion ﬂux (F, the number
of particles per second per unit area of tissue) of the contrast agent
was calculated using the bulk concentration values. Subsequently,
the ﬂux was calculated by ﬁtting a bi-exponential function to the
concentration time series, taking the time derivative of the function
and multiplying the derivative with cartilage thickness.Statistical analyses
Statistical analyses were conducted with SPSS 14.0 (SPSS Inc.,
Chicago, IL, USA) and MATLAB. Pearson’s correlation analysis was
used to calculate linear correlation coefﬁcients between contrast
agent concentration, diffusivity, diffusion ﬂux and biochemical
properties (H2O, UA and HYP content). The analyses wereE
F
D
ial (A, D), middle (B, E) and deep zones (C, F) for samples with alternating penetration
tatistically signiﬁcant (p< 0.05) difference between the sample groups. The diffusion
hereas diffusion through deep cartilage is notably slower [Fig. 3(A)]. Increased gado-
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deep to superﬁcial, intact and degenerated). The differences
between paired sample groups (superﬁcial to deep vs deep to
superﬁcial and intact vs degenerated) were investigated using the
Wilcoxon signed-rank test separately for each imaging timepoint
and cartilage layer.
Results
Enzymatically degraded samples exhibited a higher gado-
pentetate concentration and lower GAG content as compared to
intact cartilage (Fig. 2). FTIRI and PLM maps showed that the
trypsin degradation had no effect on the collagen orientation and
distribution (Fig. 2). For further analyses, the ROIs from all modal-
ities were averaged to spatial proﬁles and normalized along the
cartilage depth.
Gadopentetate concentration over time
A continuous increase in the gadopentetate concentration up to
18 hwas observed in all analyzed cartilage layers and sample groups;
the concentration increased rapidly during the ﬁrst 2 h, levelling outA
B
C
Fig. 4. Average (n¼ 6 per sample group) gadopentetate concentration proﬁles across cart
degraded samples (D). Statistical signiﬁcance (p¼ 0.031) between sample groups is indicate
the concentration proﬁles are signiﬁcantly different at 1.5 h from immersion, but the differen
1.5 h, but not at 18 h. The GAG distribution proﬁles, as measured by OD (E) indicate statistic
alternating penetration directions (B). FTIRI did not reveal signiﬁcant differences in collageafter 4e6 h from immersion (Fig. 3). When the gadopentetate was
allowed to penetrate through deep cartilage, lower concentration
values were observed particularly in superﬁcial cartilage [Fig. 3(A)].
However, the same concentration at the end of the 18-hour experi-
ment in deep cartilage was reached regardless of the diffusion route
[Fig. 3(C)]. The difference in the concentrations between the different
penetration routes was statistically signiﬁcant (p¼ 0.031, shaded
area) after the immersion up to approximately 3.5 h [Fig. 3(AeC)].
Trypsin-digested cartilage showed increased gadopentetate
concentration in the superﬁcial and middle layers [Fig. 3(DeE)],
whereas in the deep cartilage, the concentration was slightly higher
in intact samples [Fig. 3(F)]. Difference in the concentration between
the degraded and intact samples was statistically signiﬁcant
(p¼ 0.031) only in superﬁcial cartilage from 1 to 5 h after the
immersion in gadopentetate [Fig. 3(D)].
Gadopentetate concentration proﬁles for alternating penetra-
tion directions over cartilage depth differed markedly at 1.5 h,
while after 18 h the difference had disappeared [Fig. 4(A)]. For these
groups, the GAG and collagen distributions [Fig. 4(BeC)] and ﬁbril
orientation angles showed no statistically signiﬁcant differences
between the groups. The difference in gadopentetate concentration
between the degraded and intact cartilage layers was statisticallyF
D
E
ilage depth for the samples with alternating penetration route (A) or for intact and
d with a circle (B, 1.5 h) or an asterisk (*, 18 h). With alternating penetration direction,
ce is absent after 18 h. Difference between intact and degraded samples is signiﬁcant at
ally signiﬁcant GAG depletion in the most 70% of cartilage and no differences between
n distribution between the sample groups (C, F).
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the difference in concentration between intact and the degraded
samples was still notable, although not statistically signiﬁcant.Effect of cartilage composition
The difference in the GAG distributions between the trypsin-
treated and intact groups indicated signiﬁcant (p¼ 0.031) GAG
depletion in the most superﬁcial 70% of the cartilage thickness, as
determined by OD [Fig 4(E)]. However, no statistically signiﬁcant
differences in collagen distributions [Fig. 4(F)] or orientation angles
were found between the degraded and intact samples. These
observations were consistent with the biochemical analyses; no
statistically signiﬁcant differences were revealed in the H2O and
HYP contents, but a signiﬁcant (p¼ 0.028) difference was seen in
the UA contents between intact and degraded samples (Table I).
A negative trend between the contrast agent concentration and UA
content was observed in all sample groups, but the correlations
were not consistently signiﬁcant (linear correlation coefﬁcient
r¼0.866 to þ0.673) (Table II).Diffusivity and diffusion ﬂux
The bulk concentration [Fig. 5(A and C)] increased continuously
up to 18 h; the diffusion ﬂux [Fig. 5(B and D)] was largest at the
beginning of the diffusion, levelling out after approximately 7 h
from immersion. The diffusivity values derived from the ﬁnite
element model20 were 44% smaller with contrast agent penetration
through deep cartilage than with penetration through articular
surface (Table I). The diffusivity was 21% higher in the intact
samples compared to the degraded samples. A negative trend was
also noted between the diffusivity and HYP content in all groups,
although no consistently signiﬁcant correlations were found
(r¼0.871 to 0.142) (Table II).Estimation of GAG concentration
Finally, the gadopentetate concentration data were converted to
GAG concentrations according to the formulae reported earlier3.
During the equilibration period, the apparent GAG concentration
was reduced from approximately 400e600 mM to around 100 mM
[Fig. 6(A, B)]. A clear difference in the depth-wise GAG concentra-
tions with respect to contrast agent penetration direction was seen
at 1.5 h, again levelling out by 18 h from immersion [Fig. 6(C)]. In
both intact and degraded sample groups, the apparent over-
estimation of deep cartilage GAG at 1.5 h from immersion was not
noted at 18 h [Fig. 6(D)].Table I
Mean [lowereupper 95% conﬁdence interval for mean] values of contrast agent concentra
content and HYP content (n¼ 6 per sample group)
Superﬁcial to deep Deep to s
C (mM) 1.5 h 0.20 [0.14e0.26] 0.13 [0.07
C (mM) 18 h 0.28 [0.23e0.34] 0.26 [0.18
D (mm2/s) 162 [13e311] 91 [28e1
H2O (%) 79.1 [76.9e81.3]
UA (mg/mg) 6.2 [4.8e7.7]
HYP (mg/mg) 16.1 [12.5e19.6]
F (mol/mm2 s) 1.5 h 6.2 [4.2e8.3] 7.0 [3.5e
F (mol/mm2 s) 18 h 0.3 [0.1e0.4] 0.4 [0.0e
* Indicates statistically signiﬁcant difference (p¼ 0.028) between sample groups. All vDiscussion
The dGEMRIC technique was initially established for the
measurement of GAG content in articular cartilage3. For accurate
GAG quantiﬁcation, the diffusivity and kinetics of the gadopente-
tate contrast agent in articular cartilage are of critical importance.
In the present study, gadopentetate kinetics over an 18-h time
period was investigated in vitro in two different models, comparing
intact and degraded tissue as well as assessing the effect of different
contrast agent penetration routes. The present results indicate that
the dGEMRIC is sensitive to cartilage degradation. However, the
time required to reach full equilibrium of the contrast agent in
cartilage is signiﬁcantly longer than previously proposed. This
affects the accuracy of the dGEMRIC technique if quantiﬁcation of
GAG content is sought, as shorter equilibration times from 1.5 to
2.5 h in vitro3,7 and 1.5 to 3 h in vivo11,12 have typically been used.
The ﬁnding of the necessity of long equilibration time, particularly
in deep cartilage, is in accordance with a previous MRI study
investigating the diffusion of gadopentetate in cartilage21, and is
also consistent with CECT ﬁndings investigating contrast agent
diffusion in cartilage13,14.
The penetration of the contrast agent into cartilage in vivo after
intravenous injection has been suggested to occur through articular
surface via synovial ﬂuid and through deep cartilage via sub-
chondral bone9. In the present study, these diffusion routes were
separately investigated in vitro by alternatively allowing the
penetration of gadopentetate through superﬁcial or through deep
cartilage. The penetration of gadopentetate was markedly slower
through the deep cartilage especially during the ﬁrst few hours of
immersion. Furthermore, the total uptake of the contrast agent
through deep cartilage at the end of the 18-h experiment was less
compared to the uptake through superﬁcial cartilage, implying
incomplete equilibration. Differences between the contrast agent
penetration routes were also reﬂected in the calculated diffusivity
and ﬂux values (Table I), although no statistically signiﬁcant
differences were found. The reference measurements indicated
identical GAG distributions for the sample groups [Fig. 4(B)], thus
the difference between the contrast agent distributions with
alternating penetration direction is not likely to result only from
the FCD of the GAGs, but is affected by other factors. Among these is
the high collagen content of the deep cartilage [Fig. 4(C)], possibly
creating steric hindrance to the penetration of the contrast agent. It
is likely that the contrast agent diffusion through subchondral bone
plate is even slower, possibly also affecting the in vivo setup. This
hypothesis is supported by a recent study reporting slower T1
decrease in deep than in superﬁcial cartilage after intravenous
contrast agent injection22.
The trypsin degradation resulted in increased gadopentetate
concentration in the superﬁcial cartilage layers, consistently with
the respective GAG distributions [Fig. 4(D, E)]. The result is in
accordance with previous dGEMRIC studies reporting sensitivity totion (C), diffusivity (D), diffusion ﬂux (F) and biochemical properties: H2O content, UA
uperﬁcial Intact Degraded
e0.20] 0.19 [0.14e0.25] 0.23 [0.19e0.28]
e0.34] 0.29 [0.20e0.37] 0.33 [0.27e0.39]
55] 523 [140e905] 412 [267e556]
79.4 [77.3e81.4] 78.7 [77.6e79.8]
6.7 [5.7e7.6] 4.5 [3.6e5.5]*
11.7 [10.1e13.2] 12.3 [11.0e13.6]
10.4] 7.1 [2.3e11.8] 8.3 [5.9e10.7]
0.7] 0.4 [0.2e0.6] 0.7 [0.3e1.1]
alues are for bulk cartilage volume.
AB
Fig. 5. Average (n¼ 6 per sample group) gadopentetate concentration in bulk cartilage volu
(B, D) for alternating penetration direction (A, B) and for intact and degraded samples (C, D).
shaded background. The bulk contrast agent concentration increases continuously up to 18
Table II
Linear correlation coefﬁcients between contrast agent concentration (C), diffusivity
(D), diffusion ﬂux (F) and biochemical properties. Correlations are calculated for bulk
cartilage values (n¼ 6 per sample group)
C (18 h) D H2O UA HYP F (1.5 h) F (18 h)
Superﬁcial to Deep
C (1.5 h) 0.711 0.163 0.765 0.724 0.035 0.363 0.815*
C (18 h) e 0.426 0.778 0.866* 0.207 0.647 0.848*
D e 0.005 0.011 0.552 0.368 0.062
H2O e 0.875* 0.419 0.116 0.925**
UA e 0.135 0.427 0.981**
HYP e 0.638 0.185
F (1.5 h) e 0.332
Deep to superﬁcial
C (1.5 h) 0.960** 0.293 0.691 0.863* 0.338 0.331 0.239
C (18 h) e 0.496 0.493 0.738 0.536 0.295 0.330
D e 0.373 0.179 0.871* 0.228 0.433
H2O e 0.875* 0.419 0.055 0.373
UA e 0.135 0.232 0.039
HYP e 0.373 0.668
F (1.5 h) e 0.870*
Intact
C (1.5 h) 0.858* 0.745 0.517 0.379 0.555 0.263 0.517
C (18 h) e 0.428 0.222 0.673 0.301 0.061 0.267
D e 0.935** 0.253 0.251 0.066 0.181
H2O e 0.372 0.005 0.140 0.050
UA e 0.128 0.410 0.480
HYP e 0.494 0.890*
F (1.5 h) e 0.814*
Degraded
C (1.5 h) 0.844* 0.308 0.254 0.301 0.652 0.716 0.311
C (18 h) e 0.115 0.567 0.225 0.514 0.658 0.227
D e 0.016 0.522 0.142 0.196 0.216
H2O e 0.726 0.244 0.102 0.438
UA e 0.308 0.641 0.588
HYP e 0.535 0.591
F (1.5 h) e 0.823*
Statistically signiﬁcant correlations are indicated with * (p< 0.05) and ** (p< 0.01).
E.-N. Salo et al. / Osteoarthritis and Cartilage 20 (2012) 117e126 123GAG depletion3,4, although no consistent correlation between the
contrast agent concentration and UA content was observed.
Surprisingly, the difference in the contrast agent concentration
between the intact and the degraded cartilage was statistically
signiﬁcant only during the ﬁrst few hours of the diffusion process
[Fig. 3(D)]. This suggests that the visualization of early superﬁcial
changes may be possible shortly after contrast agent administra-
tion. The sensitivity to GAG depletion seems to be greatest in the
early stages of the diffusion process, indicating that the efﬁcient
visualization of GAG-depleted areas does not necessarily require
full equilibrium. Similar results were reported by Tiderius et al12,23,
suggesting higher sensitivity to cartilage degeneration at earlier
imaging time points in knee and hip dGEMRIC studies. These
results strongly suggest the possibility of an early dGEMRIC
assessment of cartilage degeneration, although the diffusion of the
contrast agent in the ﬁrst few hours from administration must be
carefully studied in vivo.
While it is relieving that dGEMRIC appears sensitive to degen-
eration prior to full equilibration, it is noteworthy that the
assumption on full equilibrium between the contrast agent and
cartilage is not fulﬁlled at the early phases of equilibration in vitro
nor in vivo22. Incomplete penetration of the contrast agent will
result in an unreliable assessment of the GAG content as theDonnan
equilibrium condition is not satisﬁed. In the present study, the
calculated GAG content was up to 50% higher at 1.5 h after immer-
sion than at 18 h [Fig. 6(B)] in intact samples. The overestimation of
GAG content due to incomplete penetration is especially evident in
the deep layers of cartilage [Fig 6(C, D)]. Incomplete diffusion is
likely to explain the uncertainties in the assessment of the GAG
content of deep cartilage reported previously7. Thus, the ability of
dGEMRIC to serve as a tool for quantifying the GAG content in
articular cartilage in clinical setting can be questioned. This is
further supported by recent ﬁndings of Li et al24, suggesting that theD
C
me (A, C, thin line), the bi-exponential ﬁts (A, C, thick line) and diffusion ﬂux over time
Statistically signiﬁcant (p¼ 0.031) difference between sample groups is indicated with
h, whereas the diffusion ﬂux decreases over time.
A C
B D
Fig. 6. Estimated average (n¼ 6 per sample group) GAG concentration over time (A for varying penetration direction, B for intact and degraded samples) and estimated GAG
concentration across cartilage depth (C for varying penetration direction, D for intact and degraded samples). Statistical signiﬁcance (p¼ 0.031) between sample groups is indicated
with a circle (B, 1.5 h) or an asterisk (*, 18 h). When the contrast agent diffusion is incomplete, GAG concentration is overestimated especially in deep layers of cartilage.
E.-N. Salo et al. / Osteoarthritis and Cartilage 20 (2012) 117e126124distribution of anionic contrast agent may not be solely due to the
GAGdistribution, butmay be affected by tissue transport properties.
No statistically signiﬁcant differences were found in the axial
diffusivities of gadopentetate when the penetration was allowed
either through deep or through superﬁcial cartilage or between
intact and trypsin-digested samples. However, a trend towards
smaller diffusivity values with penetration through deep cartilage
was seen for all samples. The lack of signiﬁcant differences may be
due to the large variation in the diffusivities of individual samples
(Table I), possibly indicating variations in the composition as well as
in cartilage thickness. This result is in agreement with previous
studies, which suggest that diffusivity depends on tissue compo-
sition25. A slight negative trend between diffusivity and HYP
content was observed, suggesting that collagen may affect gado-
pentetate penetration. The difference to the previously reported
diffusivity values26 is likely due to the different diffusion geome-
tries and thus the results are not directly comparable. Besides
diffusivity, the diffusion ﬂux over time provides an interesting
metric for the assessment of the diffusion properties of cartilage.
The difference in diffusion ﬂux between intact and degraded
samples [Fig. 5(D)] indicated that the difference in the concentra-
tions is largest at 2 h after the administration, further supporting
the idea of early dGEMRIC assessment.
Several limitations are related to the present study. The small
number of samples and relatively large variations within the
sample groups may have lead to the loss of statistically signiﬁcant
correlations and differences. Furthermore, the bovine cartilage
used in this study may have different diffusion properties than
human cartilage. Also, in order to determine the absolute concen-
tration of gadopentetate in cartilage, the spatial relaxivity ofgadopentetate in the sample should be known, as the relaxivity has
been shown to depend on the macromolecular content of the
tissue26e28. The assumed constant relaxivity valuemay have lead to
an overestimation of the gadopentetate concentration especially in
deep cartilage. However, the deﬁnition of relaxivity affects only the
absolute concentration values, while the relative differences
between the sample groups remain the same. Additionally, change
in the concentration of the equilibrating contrast agent medium
could also affect the observed concentration in the cartilage over
time. In this study, the concentration of the contrast agent in the
solution above the samples was monitored and no signiﬁcant
changes could be detected during the 18 h equilibration.
According to the present results, the contrast agent equilibration
is incomplete at clinically feasible delays of 1.5e3 h, introducing
potential errors if GAG quantiﬁcation is sought. Interestingly, the
sensitivity to cartilage degeneration seems to be greatest at these
timepoints. Several other factors affecting the gadopentetate
distribution in cartilage can be identiﬁed in a typical clinical
dGEMRIC experiment. Firstly, the contrast agent penetration into
cartilage is signiﬁcantly affected by the exercise protocol preceding
the imaging. This has been demonstrated both in animal studies29
and in clinical setting11,30,31 with decreasing T1 values after loading
or exercise, indicating that loading of the joint facilitates contrast
agent penetration. Further, cartilage loading may affect the speci-
ﬁcity of dGEMRIC to GAG content, since the solute concentration in
porous media through compression-induced convection may even
exceed that of the external bathing concentration32. In addition to
external loading, intrinsic contrast agent wash-in and wash-out
processes contribute to the total amount of gadopentetate in
cartilage. In the superﬁcial cartilage, the contrast agent wash-out is
E.-N. Salo et al. / Osteoarthritis and Cartilage 20 (2012) 117e126 125suggested to begin 3e4 h from the administration while the
concentration in deep cartilage is still increasing22. These issues
need to be carefully assessed if the GAG content in vivo is to be
accurately quantiﬁed using dGEMRIC. However, it must be noted
that the absolute GAG quantiﬁcation may not be necessary for all
clinical research questions.
In conclusion, the passive diffusion of gadopentetate into
articular cartilage was found to be signiﬁcantly slower than previ-
ously assumed, leading to a notable overestimation of the GAG
content at typically used imaging times. Moreover, the diffusion
through the deep cartilage was limited as compared to diffusion
through superﬁcial cartilage. Gadopentetate distribution in carti-
lagewas found to be related not only to the GAG content, but also to
the overall macromolecular content, indicating that also the
collagen network may have an effect on the gadopentetate accu-
mulation. These ﬁndings have implications on the in vivo applica-
tion of the technique that have to be carefully evaluated in the
future. However, while the speciﬁcity of dGEMRIC to GAG content is
hindered by the aforementioned factors, it appears that the visu-
alization of cartilage degeneration is possible shortly after the
contrast agent administration.
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